General MedicationsINJECTIONGeneric
ANCEF IN PLASTIC CONTAINER
CEFAZOLIN SODIUM
Standard Dose
EQ 20MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ANCEF IN PLASTIC CONTAINER is listed in Drugs@FDA under application 063002 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFAZOLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 20MG BASE/ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2016-02-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview ANCEF IN PLASTIC CONTAINER is listed in Drugs@FDA under application 063002 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFAZOLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 20MG BASE/ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2016-02-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.